During this interactive symposium, Dr Jeffrey Cummings (chair), Dr Liana Apostolova, Dr Oskar Hansson and Prof. Charlotte Teunissen will examine the importance of prioritizing a timely and accurate diagnosis of Alzheimer’s disease (AD) based on the underlying biology, and how current diagnostic challenges and barriers may be addressed through the use of blood-based biomarkers. The expert panel will discuss the latest key clinical data supporting the use of blood-based biomarkers in the diagnosis and treatment of AD and look at how they may be incorporated into clinical practice to facilitate the diagnostic and prognostic workup of patients with AD for early disease management. The symposium will feature several live voting and Q&A sessions to ensure ample opportunity for engagement with the faculty.

This CME-accredited Symposium is funded by an independent medical education grant from Eli Lilly and Company and is jointly provided by USF Health and touchIME. This session is not included in the main event CME/CPD credit.